CIFoundry

The clinical decision support exemption: when AI software isn’t an FDA device

Many AI tools sold to clinicians, from chart summarizers to risk scores, are marketed as "not a medical device". Often that rests on the clinical decision support (CDS) exemption in the 21st Century Cures Act.

This explainer covers what the exemption requires and what to ask when a vendor relies on it. It is general information, not legal or regulatory advice about any specific tool.

Last reviewed November 2026 · Independent and vendor-neutral

The four criteria

Software is excluded from the device definition only if it meets all four (FD&C Act section 520(o)(1)(E)).

The software must

  • 1. Not acquire, process or analyze a medical image, a signal from an in vitro diagnostic, or a pattern or signal from a signal acquisition system (such as an ECG or EEG). Tools that read images or waveforms are devices.
  • 2. Display, analyze or print medical information, such as patient data, clinical studies or practice guidelines.
  • 3. Support or provide recommendations to a health care professional about prevention, diagnosis or treatment. Tools aimed at patients don’t qualify.
  • 4. Let the professional independently review the basis for the recommendation, so they don’t rely mainly on the software.

What FDA’s January 2026 guidance changed

Key points

  • FDA revised its CDS guidance in January 2026, replacing the 2022 version.
  • Software that gives a single recommendation is no longer automatically treated as a device: FDA says it will use enforcement discretion when that one output is clinically appropriate and the other criteria are met.
  • Time-critical use still counts against the exemption. When a clinician has no time to review the basis, FDA sees a higher risk of automation bias.
  • The guidance puts more weight on presenting decision-relevant information clearly, without overload, so the clinician can actually check the reasoning.

Questions to ask a vendor who says "not a device"

Ask

  • Which of the four criteria do you rely on, and do you have a written regulatory assessment you can share?
  • Does any part of the product analyze images, waveforms or device signals? If so, which parts are FDA-cleared and which are not?
  • What exactly does the clinician see to check the basis of a recommendation: inputs used, logic, sources, known limits?
  • Is it used in time-critical settings (emergency, ICU, stroke) where review time is short?
  • If FDA’s view changes, what is your plan, and what happens to our contract?

Remember

  • "Not a device" means no FDA premarket review. Your own validation, monitoring and governance matter even more.
  • Your hospital still owns how the tool is used. Liability questions don’t go away because software is outside FDA rules.
Whatever the tool does, the 12 core questions (evidence, data rights, liability, monitoring, contracts) also apply.

Further reading

More on rules & regulations

Last reviewed November 2026. Educational information, not medical, legal or regulatory advice, and not advice about any specific tool or patient. Rules change; check the linked official sources.

No vendor reviewed, sponsored or edited this guide. Listing is free; no one can pay to change the order.